PPARGC1A and myocardial ischemia: ISOV exerts cardioprotective effects against myocardial ischemia by directly binding to SLC25A4 and activating the AMPK/PGC-1α pathway, highlighting its potential as a therapeutic agent for myocardial ischemia.